CG Oncology Inc.(CGON)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CGON CG Oncology Inc.

已收盘 07-24 16:00:00 EDT

69.32

-1.80

-2.53%

盘后69.32

+0.000.00%

19:34 EDT

最高71.02	最低68.96	成交量36.88万
今开71.02	昨收71.12	日振幅2.90%
总市值61.01亿	流通市值45.63亿	总股本8,801万
成交额2,564万	换手率0.56%	流通股本6,582万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CGON","market":"US","secType":"STK","nameCN":"CG Oncology Inc.","latestPrice":69.32,"timestamp":1784923200000,"preClose":71.12,"halted":0,"volume":368760,"hourTrading":{"tag":"盘后","latestPrice":69.32,"preClose":69.32,"latestTime":"19:34 EDT","volume":17775,"amount":1232164.68,"timestamp":1784936047020,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.025309336332958537,"floatShares":65824000,"shares":88009980,"eps":-2.352362,"marketStatus":"已收盘","change":-1.8,"latestTime":"07-24 16:00:00 EDT","open":71.02,"high":71.02,"low":68.96,"amount":25639646.7936,"amplitude":0.028965,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.352362,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1785139200000},"marketStatusCode":5,"adr":0,"listingDate":1706158800000,"exchange":"NASDAQ","adjPreClose":71.12,"preHourTrading":{"tag":"盘前","latestPrice":71.12,"preClose":71.12,"latestTime":"09:29 EDT","volume":332,"amount":23837.09702,"timestamp":1784899799915,"change":0,"changeRate":0,"amplitude":0.056243},"postHourTrading":{"tag":"盘后","latestPrice":69.32,"preClose":69.32,"latestTime":"19:34 EDT","volume":17775,"amount":1232164.68,"timestamp":1784936047020,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.408914,"impliedVol":1.003,"impliedVolPercentile":0.8207},"requestUrl":"/m/hq/s/CGON","defaultTab":"news","newsList":[{"id":"1196709641","title":"ANI Pharmaceuticals 宣布拟就CG Oncology相关裁决提出上诉","url":"https://stock-news.laohu8.com/highlight/detail?id=1196709641","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196709641?lang=zh_cn&edition=full","pubTime":"2026-07-17 06:34","pubTimestamp":1784241277,"startTime":"0","endTime":"0","summary":"ANI Pharmaceuticals Inc. 宣布，计划就与CG Oncology Inc.相关诉讼中的裁决提出上诉。此前，初审法院已驳回该公司提出的重新审理及判决的动议。\n该公司表示，将继续寻求追回其在2010年出售给CG Oncology的资产价值。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANIP","BK4007","LU1559883803.SGD","SBIO","CGON","BK4139","LU0566484027.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158196355","title":"CG Oncology Inc. 疗法在BCG暴露与无响应患者群体中疗效相当","url":"https://stock-news.laohu8.com/highlight/detail?id=1158196355","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158196355?lang=zh_cn&edition=full","pubTime":"2026-05-15 20:10","pubTimestamp":1778847042,"startTime":"0","endTime":"0","summary":"CG Oncology Inc. 发布的数据显示，其候选疗法在治疗臂之间，以及对于BCG暴露或BCG无响应的患者群体，均表现出可比的疗效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CGON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152197639","title":"CG Oncology Inc. 公布ITT人群高分级无事件生存率：3个月达96.0%，6个月为89.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1152197639","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152197639?lang=zh_cn&edition=full","pubTime":"2026-05-15 20:09","pubTimestamp":1778846956,"startTime":"0","endTime":"0","summary":"CG Oncology Inc. 发布的最新数据显示，在意向治疗（ITT）人群中，其疗法展现出了令人瞩目的高分级无事件生存率。具体而言，在治疗后的3个月时间点，该比率高达96.0%；而到第6个月时，这一数据依然保持在89.5%的强劲水平。这些结果突显了该疗法在短期至中期随访中的有效性与持久性潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CGON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172418136","title":"CG Oncology公布CORE-008研究Cx队列二期试验积极初步结果，评估高危BCG暴露及无应答患者膀胱灌注联合疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=1172418136","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172418136?lang=zh_cn&edition=full","pubTime":"2026-05-15 20:01","pubTimestamp":1778846507,"startTime":"0","endTime":"0","summary":"CG Oncology公布了其CORE-008临床研究中Cx队列二期试验的积极初步数据。该试验旨在评估一种膀胱灌注联合疗法，用于治疗高危、对卡介苗暴露后无应答的膀胱癌患者。\n试验结果显示，该联合治疗方案在患者中取得了令人鼓舞的初步疗效。这些数据为针对这一难治性患者群体的创新疗法开发提供了新的希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CGON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122257945","title":"CG Oncology Inc. 持有9.03亿美元现金及等价物与有价证券 可支持运营至2029年上半年","url":"https://stock-news.laohu8.com/highlight/detail?id=1122257945","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122257945?lang=zh_cn&edition=full","pubTime":"2026-02-27 21:38","pubTimestamp":1772199491,"startTime":"0","endTime":"0","summary":"CG Oncology Inc. 最新财务数据显示，公司目前持有的现金、现金等价物及有价证券总额达9.03亿美元。这一资金规模预计足以支撑公司现有运营计划持续至2029年上半年。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CGON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517292560","title":"Cg Oncology, Inc.盘中异动 下午盘股价大涨5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517292560","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517292560?lang=zh_cn&edition=full","pubTime":"2025-03-06 03:13","pubTimestamp":1741201998,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日03时13分，Cg Oncology, Inc.股票出现异动，股价大幅拉升5.28%。Cg Oncology, Inc.股票所在的生物技术行业中，整体涨幅为2.13%。其相关个股中，Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为957.73%、312.80%、305.67%，振幅较大的相关个股有Nkgen Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Marker Therapeutics, Inc.，振幅分别为82.59%、54.27%、50.73%。Cg Oncology, Inc.公司简介：CG Oncology Inc 是一家后期临床生物制药公司，专注于为膀胱癌患者开发和商业化潜在的膀胱保留疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306031319a26115f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306031319a26115f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CGON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516372580","title":"Cg Oncology, Inc.盘中异动 股价大涨5.11%报25.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516372580","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516372580?lang=zh_cn&edition=full","pubTime":"2025-03-01 01:09","pubTimestamp":1740762542,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日01时09分，Cg Oncology, Inc.股票出现异动，股价大幅拉升5.11%。截至发稿，该股报25.90美元/股，成交量14.4714万股，换手率0.19%，振幅6.47%。Cg Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.48%。Cg Oncology, Inc.公司简介：CG Oncology Inc 是一家后期临床生物制药公司，专注于为膀胱癌患者开发和商业化潜在的膀胱保留疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301010903a25827ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301010903a25827ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CGON","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514459011","title":"Cg Oncology, Inc.盘中异动 大幅跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514459011","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514459011?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:17","pubTimestamp":1740500223,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时17分，Cg Oncology, Inc.股票出现波动，股价急速跳水5.00%。Cg Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.65%。其相关个股中，Organovo Holdings, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Silexion Therapeutics Corp涨幅较大，Organovo Holdings, Inc.、Gt Biopharma, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为1309.06%、1112.97%、892.96%，振幅较大的相关个股有Organovo Holdings, Inc.、Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 ，振幅分别为224.93%、87.83%、66.67%。Cg Oncology, Inc.公司简介：CG Oncology Inc 是一家后期临床生物制药公司，专注于为膀胱癌患者开发和商业化潜在的膀胱保留疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226001703a2539f3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226001703a2539f3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CGON","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508417561","title":"Cg Oncology, Inc.盘中异动 早盘快速下跌5.02%报28.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508417561","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508417561?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:56","pubTimestamp":1738594575,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时56分，Cg Oncology, Inc.股票出现异动，股价急速下跌5.02%。截至发稿，该股报28.56美元/股，成交量1.3501万股，换手率0.02%，振幅3.23%。Cg Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.52%。Cg Oncology, Inc.公司简介：CG Oncology Inc 是一家后期临床生物制药公司，专注于为膀胱癌患者开发和商业化潜在的膀胱保留疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322561598797338&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322561598797338&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CGON","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503237896","title":"Cg Oncology, Inc.盘中异动 早盘快速上涨5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503237896","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503237896?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:49","pubTimestamp":1736952591,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时49分，Cg Oncology, Inc.股票出现波动，股价快速上涨5.29%。截至发稿，该股报29.45美元/股，成交量1.4386万股，换手率0.02%，振幅3.54%。Cg Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.90%。Cg Oncology, Inc.公司简介：CG Oncology Inc 是一家后期临床生物制药公司，专注于为膀胱癌患者开发和商业化潜在的膀胱保留疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011522495198674027&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011522495198674027&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CGON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503587382","title":"Cg Oncology, Inc.盘中异动 股价大跌5.23%报28.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503587382","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503587382?lang=zh_cn&edition=full","pubTime":"2025-01-14 00:16","pubTimestamp":1736784970,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日00时16分，Cg Oncology, Inc.股票出现波动，股价大幅下挫5.23%。截至发稿，该股报28.62美元/股，成交量16.5209万股，换手率0.22%，振幅4.14%。Cg Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.96%。Cg Oncology, Inc.公司简介：CG Oncology Inc 是一家后期临床生物制药公司，专注于为膀胱癌患者开发和商业化潜在的膀胱保留疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011400161196026583&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011400161196026583&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CGON","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501733311","title":"TD Cowen对CG Oncology首次覆盖评级为买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2501733311","media":"同花顺iNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501733311?lang=zh_cn&edition=full","pubTime":"2025-01-08 02:03","pubTimestamp":1736272984,"startTime":"0","endTime":"0","summary":"同花顺美股讯 1月7日TD Cowen评级报告首次覆盖cg oncology，首次评级为买入。CG Oncology于11月12日发布2024年三季报，公司截至2024年9月30日，营业收入68.30万美元，同比236.45%，净利润-5624.10万美元，基本每股收益-0.93美元。CG Oncology， Inc.最初成立于2010年9月24日，是一家加州公司，名称为Cold Genesys， Inc.。2017年11月30日，该公司重新注册为特拉华州公司，并于2020年3月31日，该公司更名为CG Oncology，Inc。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108020516a21913a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108020516a21913a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CG","CGON","TD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501785234","title":"Cg Oncology, Inc.盘中异动 早盘股价大涨5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501785234","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501785234?lang=zh_cn&edition=full","pubTime":"2025-01-07 22:47","pubTimestamp":1736261229,"startTime":"0","endTime":"0","summary":"北京时间2025年01月07日22时47分，Cg Oncology, Inc.股票出现波动，股价快速拉升5.38%。截至发稿，该股报31.32美元/股，成交量11.7121万股，换手率0.15%，振幅3.10%。Cg Oncology, Inc.股票所在的生物技术行业中，整体涨幅为1.19%。Cg Oncology, Inc.公司简介：CG Oncology Inc 是一家后期临床生物制药公司，专注于为膀胱癌患者开发和商业化潜在的膀胱保留疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010722470995fba13d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010722470995fba13d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4563","CGON","BK4139","IMRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500149210","title":"Cg Oncology, Inc.盘中异动 临近午盘股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500149210","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500149210?lang=zh_cn&edition=full","pubTime":"2025-01-04 00:49","pubTimestamp":1735922945,"startTime":"0","endTime":"0","summary":"北京时间2025年01月04日00时49分，Cg Oncology, Inc.股票出现波动，股价急速拉升5.01%。截至发稿，该股报30.42美元/股，成交量32.0301万股，换手率0.42%，振幅5.76%。Cg Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.66%。Cg Oncology, Inc.公司简介：CG Oncology Inc 是一家后期临床生物制药公司，专注于为膀胱癌患者开发和商业化潜在的膀胱保留疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250104004905985a538c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250104004905985a538c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CGON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2495894524","title":"Cg Oncology, Inc.盘中异动 股价大跌5.09%报28.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2495894524","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495894524?lang=zh_cn&edition=full","pubTime":"2024-12-30 23:18","pubTimestamp":1735571880,"startTime":"0","endTime":"0","summary":"北京时间2024年12月30日23时18分，Cg Oncology, Inc.股票出现波动，股价大幅跳水5.09%。截至发稿，该股报28.51美元/股，成交量5.0834万股，换手率0.07%，振幅3.00%。Cg Oncology, Inc.股票所在的生物技术行业中，整体跌幅为1.18%。Cg Oncology, Inc.公司简介：CG Oncology Inc 是一家后期临床生物制药公司，专注于为膀胱癌患者开发和商业化潜在的膀胱保留疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123023180098553015&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123023180098553015&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CGON","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2491368603","title":"Cg Oncology, Inc.盘中异动 早盘大幅跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491368603","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491368603?lang=zh_cn&edition=full","pubTime":"2024-12-13 00:02","pubTimestamp":1734019332,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日00时02分，Cg Oncology, Inc.股票出现波动，股价快速下挫5.00%。截至发稿，该股报30.15美元/股，成交量11.0055万股，换手率0.16%，振幅4.33%。Cg Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.97%。Cg Oncology, Inc.公司简介：CG Oncology Inc 是一家后期临床生物制药公司，专注于为膀胱癌患者开发和商业化潜在的膀胱保留疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121300021395e93a7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121300021395e93a7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CGON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2490635678","title":"Cg Oncology, Inc.盘中异动 快速下跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490635678","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490635678?lang=zh_cn&edition=full","pubTime":"2024-12-11 22:30","pubTimestamp":1733927428,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日22时30分，Cg Oncology, Inc.股票出现异动，股价快速下跌5.04%。Cg Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Candel Therapeutics, Inc.、Dermata Therapeutics Inc C/Wts 、Nutriband Inc C/Wts 涨幅较大，Silexion Therapeutics Corp、Candel Therapeutics, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为363.25%、100.53%、97.15%，振幅较大的相关个股有Bioline Rx Ltd、Candel Therapeutics, Inc.、Cogent Biosciences, Inc.，振幅分别为5.03%、4.01%、3.39%。Cg Oncology, Inc.公司简介：CG Oncology Inc 是一家后期临床生物制药公司，专注于为膀胱癌患者开发和商业化潜在的膀胱保留疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211223029ab6fc92d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211223029ab6fc92d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CGON","BK4139","BK4539","CADL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2489234240","title":"Cg Oncology, Inc.盘中异动 早盘股价大涨5.04%报35.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489234240","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489234240?lang=zh_cn&edition=full","pubTime":"2024-12-06 23:24","pubTimestamp":1733498642,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日23时24分，Cg Oncology, Inc.股票出现波动，股价急速上涨5.04%。截至发稿，该股报35.25美元/股，成交量13.7872万股，换手率0.20%，振幅3.99%。Cg Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.71%。Cg Oncology, Inc.公司简介：CG Oncology Inc 是一家后期临床生物制药公司，专注于为膀胱癌患者开发和商业化潜在的膀胱保留疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206232402ab62f10e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206232402ab62f10e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CGON","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2489117913","title":"Cg Oncology, Inc.盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489117913","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489117913?lang=zh_cn&edition=full","pubTime":"2024-12-05 01:42","pubTimestamp":1733334147,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日01时42分，Cg Oncology, Inc.股票出现波动，股价大幅上涨5.00%。截至发稿，该股报36.65美元/股，成交量24.8088万股，换手率0.37%，振幅4.24%。Cg Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。Cg Oncology, Inc.公司简介：CG Oncology Inc 是一家后期临床生物制药公司，专注于为膀胱癌患者开发和商业化潜在的膀胱保留疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205014227971ba8ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205014227971ba8ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CGON","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2484130639","title":"Cg Oncology, Inc.2024财年第三财季实现净利润-20.41百万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484130639","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484130639?lang=zh_cn&edition=full","pubTime":"2024-11-19 18:00","pubTimestamp":1732010419,"startTime":"0","endTime":"0","summary":"11月19日，Cg Oncology, Inc.公布财报，公告显示公司2024财年第三财季净利润为-20.41百万美元；其中营业收入为43000.00美元，每股基本收益为-0.30美元。从资产负债表来看，Cg Oncology, Inc.总负债15.70百万美元，其中短期债务225000.00美元，资产负债比为0.36，流动比率为0.36。机构评级：截至2024年11月19日，当前有8家机构对Cg Oncology, Inc.目标价做出预测，其中目标均价为66.62美元，其中最低目标价为51.00美元，最高目标价为86.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119180028a24561c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119180028a24561c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CGON"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://cgoncology.com;ir.cgoncology.com","stockEarnings":[{"period":"1week","weight":0.0233},{"period":"1month","weight":0.082},{"period":"3month","weight":0.0355},{"period":"6month","weight":0.3217},{"period":"1year","weight":1.7021},{"period":"ytd","weight":0.7129}],"compareEarnings":[{"period":"1week","weight":-0.0167},{"period":"1month","weight":0.0063},{"period":"3month","weight":0.034},{"period":"6month","weight":0.071},{"period":"1year","weight":0.1639},{"period":"ytd","weight":0.0825}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"CG Oncology, Inc.最初成立于2010年9月24日的加利福尼亚州公司，随后于2017年11月30日重新注册为特拉华州公司。该公司是一家后期临床生物制药公司，专注于开发和商业化cretostimogene grenadenorepvec，一种用于治疗膀胱癌的研究性溶瘤免疫疗法。其临床项目针对治疗选择有限的高危和中危非肌肉浸润性膀胱癌患者。","exchange":"NASDAQ","name":"CG Oncology Inc.","nameEN":"CG Oncology Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CG Oncology Inc.(CGON)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CG Oncology Inc.(CGON)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CG Oncology Inc.,CGON,CG Oncology Inc.股票,CG Oncology Inc.股票老虎,CG Oncology Inc.股票老虎国际,CG Oncology Inc.行情,CG Oncology Inc.股票行情,CG Oncology Inc.股价,CG Oncology Inc.股市,CG Oncology Inc.股票价格,CG Oncology Inc.股票交易,CG Oncology Inc.股票购买,CG Oncology Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CG Oncology Inc.(CGON)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CG Oncology Inc.(CGON)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}